Back to Search
NICHOLAS MARKHAM, M.D., PH.D.
M.D., PH.D.
Gastroenterology Physician
NPI: 1710307749Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
60896(TN)
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
60896(TN)
Research & Publications (20)
UNAFold: software for nucleic acid folding and hybridization.
PMID 18712296·Methods Mol Biol·2008
8-other
Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro.
PMID 18621906·Am J Physiol Lung Cell Mol Physiol·2008
7-preclinical
Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition.
PMID 17827251·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling.
PMID 17823355·Am J Respir Crit Care Med·2007
7-preclinical
An 11-amino acid beta-hairpin loop in the cytoplasmic domain of band 3 is responsible for ankyrin binding in mouse erythrocytes.
PMID 17715300·Proc Natl Acad Sci U S A·2007
7-preclinical
Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia.
PMID 17209139·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia.
PMID 16829629·Am J Physiol Lung Cell Mol Physiol·2006
7-preclinical
BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
PMID 16582538·Biol Neonate·2006
7-preclinical
Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia.
PMID 16443642·Am J Physiol Lung Cell Mol Physiol·2006
7-preclinical
Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats.
PMID 15908474·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats.
PMID 15879297·Pediatr Res·2005
7-preclinical
rhVEGF treatment preserves pulmonary vascular reactivity and structure in an experimental model of pulmonary hypertension in fetal sheep.
PMID 15833763·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Pulmonary hypertension impairs alveolarization and reduces lung growth in the ovine fetus.
PMID 15579625·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.
PMID 15064225·Am J Physiol Lung Cell Mol Physiol·2004
7-preclinical
Provocation poliomyelitis: vaccine associated paralytic poliomyelitis related to a rectal abscess in an infant.
PMID 12850168·J Infect·2003
5-case
Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus.
PMID 12573989·Am J Physiol Lung Cell Mol Physiol·2003
7-preclinical
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.
PMID 12169575·Am J Physiol Lung Cell Mol Physiol·2002
7-preclinical
Evaluation of fungal growth on cellulose-containing and inorganic ceiling tile.
PMID 11407495·Mycopathologia·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1301 MEDICAL CENTER DR, 1660 THE VANDERBILT CLINIC
NASHVILLE, TN 37232 - Phone
- (615) 322-0128
Quick Facts
- NPI
- 1710307749
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile